Private equity firm on why it backed a North African pharma producer Published by Justin Probyn on 15 September 2016 Actis recently invested in Medis Group – a producer of generic pharmaceuticals in Tunisia and Algeria.
Actis invests in Medis, acquires AfricInvest stake Published by Press Office on 5 September 2016 Actis will also inject further funds into the business to finance a buy-and-build strategy to create a leading pan-African/Middle-Eastern pharmaceutical business.
